About
Aclarion Inc (NASDAQ:ACON) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Aclarion Announces $2.5 Million Stock Repurchase Plan
Apr 16 2026
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Apr 14 2026
Aclarion Receives Pinnacle Award for AI Innovation
Apr 8 2026
Aclarion Announces Agreement with Weill Cornell Medicine
Apr 7 2026
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Financials
Revenue
$75.73 K
Market Cap
$7.99 M
EPS
-13.34
Translate